Detalhe da pesquisa
1.
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.
Cell Rep Med
; 3(10): 100783, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260981